Regulatory & Quality Spend Gap Shrinks 25%: New Report Reveals How MedTech Leaders Are Rebalancing Compliance Investments
CHAPEL HILL, N.C., Aug. 18, 2025/ -- In today’s rapidly advancing MedTech environment, Regulatory and Quality (RAQA) functions are no longer just about meeting compliance—they are emerging as strategic enablers of efficiency, innovation, and competitive advantage.
Best Practices, LLC’s latest benchmarking study, "Inside MedTech Compliance: Benchmarking the People, Processes, and Costs Behind Regulatory and Quality Excellence," examines how investment priorities are shifting, with the gap between Regulatory and Quality spending narrowing by 25 percentage points over recent years. This trend signals a clear move toward a more balanced, integrated compliance strategy.
Drawing insights from 63 MedTech business units, including an update cohort of 10 leading organizations, the research provides data-driven benchmarks and strategic guidance for leaders navigating mounting challenges — from AI integration to evolving global regulations, consent decrees, and CIA obligations.
Key Topics Explored in the Report
- Shifting Regulatory & Quality investment strategies and cost structures
- Impact of business focus and product mix on compliance demands
- Organizational models and shared services optimization
- Leveraging AI, data analytics, and digital tools for cost containment
- Workforce evolution and regional staffing strategies
This report gives MedTech RAQA leaders the peer-driven insights they need to make smarter investments, strengthen compliance readiness, and turn regulatory complexity into a competitive advantage.
For a deeper dive, download the complimentary report summary here: https://www.best-in-class.com/rw489.htm
Pressed for time? Watch the short video summary below to uncover the key findings and recommendations from the study: